GSTM1 and autoimmune hemolytic anemia: In this case, even immunosuppressive was not keeping the Hb near the baseline or stabilizing hemolysis markers; thus, proteasome inhibitors have been used to treat AIHA due to their ability to induce plasma cell apoptosis [10-12].